Cargando…

Molecular Mechanisms Underlying the Cardiovascular Toxicity of Specific Uremic Solutes

Mounting evidence strongly suggests a causal link between chronic kidney disease (CKD) and cardiovascular disease (CVD). Compared with non-CKD patients, patients with CKD suffer disproportionately from CVD and derive suboptimal benefits from interventions targeting conventional CVD risk factors. Ure...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ravid, Jonathan D., Chitalia, Vipul C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565564/ https://www.ncbi.nlm.nih.gov/pubmed/32887404 http://dx.doi.org/10.3390/cells9092024

Ejemplares similares

A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum
por: Zhang, Anqi, et al.
Publicado: (2017)

Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations
por: Ravid, Jonathan D., et al.
Publicado: (2022)

Uremic Toxin Clearance and Cardiovascular Toxicities
por: Mair, Robert D., et al.
Publicado: (2018)

Gut Microbiota and Cardiovascular Uremic Toxicities
por: Velasquez, Manuel T., et al.
Publicado: (2018)

The Microbiome and Uremic Solutes
por: Zaidan, Nadim, et al.
Publicado: (2022)

What is new in uremic toxicity?
por: Vanholder, Raymond, et al.
Publicado: (2008)

The Evolving View of Uremic Toxicity
por: Meijers, Bjorn, et al.
Publicado: (2022)

Bone Marrow and Adipose Tissue Adenosine Receptors Effect on Osteogenesis and Adipogenesis
por: Eisenstein, Anna, et al.
Publicado: (2020)

Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies
por: Mitrea, Laura, et al.
Publicado: (2023)

Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets
por: Lim, Yong Jin, et al.
Publicado: (2021)

An Enlarged Profile of Uremic Solutes
por: Tanaka, Hisae, et al.
Publicado: (2015)

Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies
por: Keir, Lindsay S, et al.
Publicado: (2012)

Emerging Factors Implicated in Fibrotic Organ–Associated Thrombosis: The Case of Two Organs
por: Leiva, Orly, et al.
Publicado: (2019)

CE-MS-Based Identification of Uremic Solutes Specific to Hemodialysis Patients
por: Akiyama, Yasutoshi, et al.
Publicado: (2021)

The role of the extracellular matrix in primary myelofibrosis
por: Leiva, O, et al.
Publicado: (2017)

Optimal management of atypical hemolytic uremic disease: challenges and solutions
por: Raina, Rupesh, et al.
Publicado: (2019)

Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction
por: Fujii, Hideki, et al.
Publicado: (2018)

c-Cbl: An Important Regulator and a Target in Angiogenesis and Tumorigenesis
por: Lyle, Chimera L., et al.
Publicado: (2019)

The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease
por: Claro, Ligia Maria, et al.
Publicado: (2018)

Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins
por: Coppola, Annapaola, et al.
Publicado: (2023)

Monoclonal IgG4/2κ Deposition Following Eculizumab Therapy for Recurrent Atypical Hemolytic Uremic Syndrome in Kidney Transplantation
por: Singh, Priyamvada, et al.
Publicado: (2019)

Uremic Toxins Affecting Cardiovascular Calcification: A Systematic Review
por: Holmar, Jana, et al.
Publicado: (2020)

Characterization of SNF472 pharmacokinetics and efficacy in uremic and non-uremic rats models of cardiovascular calcification
por: Ferrer, Miguel D., et al.
Publicado: (2018)

Molecular Mechanisms Underlying Neuroinflammation Elicited by Occupational Injuries and Toxicants
por: Pathak, Dhruba, et al.
Publicado: (2023)

Biochemical and Clinical Impact of Organic Uremic Retention Solutes: A Comprehensive Update
por: Vanholder, Raymond, et al.
Publicado: (2018)

The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes
por: Etinger, Aleksey, et al.
Publicado: (2018)

Contribution of Gut Microbiota-Derived Uremic Toxins to the Cardiovascular System Mineralization
por: Filipska, Iwona, et al.
Publicado: (2021)

Uremic Solutes in Chronic Kidney Disease and Their Role in Progression
por: van den Brand, Jan A. J. G., et al.
Publicado: (2016)

An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity
por: Cisbani, G, et al.
Publicado: (2012)

Uremic osteoporosis
por: Kazama, Junichiro J, et al.
Publicado: (2013)

Uremic Toxins and Atrial Fibrillation: Mechanisms and Therapeutic Implications
por: Yamagami, Fumi, et al.
Publicado: (2019)

Molecular Mechanism Underlying Role of the XBP1s in Cardiovascular Diseases
por: Liu, Shu, et al.
Publicado: (2022)

Cardio-Oncology: mechanisms of cardiovascular toxicity
por: Markman, Timothy M., et al.
Publicado: (2018)

What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis
por: Vanholder, Raymond, et al.
Publicado: (2022)

A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
por: Chitalia, Vipul C., et al.
Publicado: (2020)

Chronic Kidney Disease and Fibrosis: The Role of Uremic Retention Solutes
por: Mutsaers, Henricus A. M., et al.
Publicado: (2015)

Correction: The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes
por: Etinger, Aleksey, et al.
Publicado: (2018)

Uremic Vascular Calcification: The Pathogenic Roles and Gastrointestinal Decontamination of Uremic Toxins
por: Chao, Chia-Ter, et al.
Publicado: (2020)

Uremic Sarcopenia
por: Mohanasundaram, Subashri, et al.
Publicado: (2022)

The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease
por: Koppe, Laetitia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cjppjcm25bgs8s0b7fdmfv279f